Bumper Offer - Urjas oil Just @ Rs. 1
Dolopar-650 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Fever, Headache, Pain. Dolopar-650 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Dolopar-650 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Dolopar-650 Tablet have been listed ahead. Such side effects of Dolopar-650 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Dolopar-650 Tablet is Safe for pregnant women and Safe for women who are breastfeeding. Warnings related to Dolopar-650 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Dolopar-650 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Dolopar-650 Tablet in conditions like Kidney Disease, Liver Disease, Drug Allergies. Some other conditions that can be affected by Dolopar-650 Tablet are listed in the contraindications section below.
Besides this, Dolopar-650 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Dolopar-650 Tablet is considered safe while driving, and is addictive.
Dolopar-650 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Dolopar-650 Tablet is used -
Severe
Mild
Is the use of Dolopar-650 Tablet safe for pregnant women?
Dolopar is safe for pregnant women.
Is the use of Dolopar-650 Tablet safe during breastfeeding?
Dolopar does not show any side effects in breastfeeding women.
What is the effect of Dolopar-650 Tablet on the Kidneys?
Dolopar has very mild side effects on the kidneys.
What is the effect of Dolopar-650 Tablet on the Liver?
Dolopar may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Dolopar-650 Tablet on the Heart?
Very few cases of side effects of Dolopar on the heart have been reported.
Dolopar-650 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Dolopar-650 Tablet unless your doctor advises you to do so -
Is this Dolopar-650 Tablet habit forming or addictive?
Dolopar-650 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Dolopar-650 Tablet since it does not cause drowsiness.
Is it safe?
Dolopar-650 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Dolopar-650 Tablet is not used to treat mental disorders.
Interaction between Food and Dolopar-650 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Dolopar-650 Tablet together with food.
Interaction between Alcohol and Dolopar-650 Tablet
Consumption of alcohol and Dolopar-650 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 488
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 488
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
